Long-term efficacy of leptin replacement in patients with familial partial lipodystrophy, Dunnigan variety (FPLD)

被引:0
|
作者
Park, Jeany
Javor, Edward D.
Cochran, Elaine K.
Depaoli, Alex M.
Gorden, Phillip
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A18 / A18
页数:1
相关论文
共 50 条
  • [1] Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy
    Park, Jean Y.
    Javor, Edward D.
    Cochran, Elaine K.
    DePaoli, Alex M.
    Gorden, Phillip
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (04): : 508 - 516
  • [2] Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety
    Simha, Vinaya
    Subramanyam, Lalitha
    Szczepaniak, Lidia
    Quittner, Claudia
    Adams-Huet, Beverley
    Snell, Peter
    Garg, Abhimanyu
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03): : 785 - 792
  • [3] Long-term efficacy of leptin replacement in patients with generalized lipodystrophy
    Javor, ED
    Cochran, EK
    Musso, C
    Young, JR
    DePaoli, AM
    Gorden, P
    DIABETES, 2005, 54 (07) : 1994 - 2002
  • [4] Long-term efficacy of leptin replacement in patients with generalized lipodystrophy
    Javor, ED
    Cochran, EK
    Musso, C
    Young, JR
    Depaoli, AM
    Gorden, P
    DIABETES, 2005, 54 : A12 - A12
  • [5] Muscular biopsy in adult patients affected by the familial partial lipodystrophy (fpld) or dunnigan syndrome
    Vantyghem, M
    Maurage, CA
    Cuisset, JM
    Vigouroux, C
    Stojkovic, T
    Girardot, C
    Vermersch, P
    Capeau, J
    DIABETOLOGIA, 2002, 45 : A230 - A231
  • [6] Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy:: efficacy of rosiglitazone
    Lüdtke, A
    Heck, K
    Genschel, J
    Mehnert, H
    Spuler, S
    Worman, HJ
    Schmidt, HHJ
    DIABETIC MEDICINE, 2005, 22 (11) : 1611 - 1613
  • [7] REGIONAL BODY FAT AND METABOLIC COMPLICATIONS IN CHILDREN WITH FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN VARIETY (FPLD2)
    Patni, Nivedita
    Adams-Huet, Beverley
    Garg, Abhimanyu
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 164 - 165
  • [8] Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety
    Haque, WA
    Oral, EA
    Dietz, K
    Bowcock, AM
    Agarwal, AK
    Garg, A
    DIABETES CARE, 2003, 26 (05) : 1350 - 1355
  • [9] Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)
    Garg, A
    Peshock, RM
    Fleckenstein, JL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01): : 170 - 174
  • [10] Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety
    Vasandani, Chandna
    Li, Xilong
    Sekizkardes, Hilal
    Adams-Huet, Beverley
    Brown, Rebecca J.
    Garg, Abhimanyu
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (07): : 2132 - 2141